BIOMERICA INC

Nasdaq:BMRA

In Vitro & In Vivo Diagnostic Substances·IRVINE, CA

CEO

Irani Zackary S.

CFO

Lu Gary

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q4 2025	11/30/25	1/14/26	→
10-Q	Q3 2025	8/31/25	10/14/25	→
10-K/A	FY 2025	5/31/25	9/26/25	→
10-K	FY 2025	5/31/25	8/29/25	→
10-Q	Q1 2025	2/28/25	4/14/25	→
10-Q	Q4 2024	11/30/24	1/14/25	→
↓

Earnings Releases (8-K)

1 shown

Filed	Period
12/16/21	Q2 FY2022	→

News (8-K)

75 shown

Filed	Type	Description
12/16/25	Vote	Submission of Matters to a Vote of Security Holders	→
10/8/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/6/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
4/16/25	Reg FD	Material Modification to Rights of Security Holders	→
12/17/24	Vote	Submission of Matters to a Vote of Security Holders	→
11/6/24	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
↓

Prospectuses & Registrations

25 shown

Filed	Form	Description
2/27/26	S-8	S-8	→
12/20/24	S-8	S-8	→
11/25/24	S-8	S-8	→
5/10/24	424B5	424B5	→
9/28/23	S-3	S-3	→
3/7/23	424B5	424B5	→
↓

Filing History(585 filings)

TypeDateAccessionPeriodSize

S-8

Feb 27, 2026

0001493152-26-008372S-8

—

215.1 KB

Jan 28, 2026

0001493152-26-0040834

Dec 12, 2025

5.1 KB

10-Q

Jan 14, 2026

0001493152-26-00228610-Q

Nov 30, 2025

4.1 MB

Dec 31, 2025

0001493152-25-0298434

Dec 12, 2025

5.1 KB

Dec 31, 2025

0001493152-25-0298424

Dec 12, 2025

5.2 KB

Dec 31, 2025

0001493152-25-0298414

Dec 12, 2025

5.1 KB

Dec 31, 2025

0001493152-25-0298394

Dec 12, 2025

5.1 KB

Dec 31, 2025

0001493152-25-0298404

Dec 12, 2025

5.1 KB

8-K

Dec 16, 2025

0001493152-25-0278918-K

Dec 12, 2025

207.8 KB

DEFA14A

Oct 23, 2025

0001493152-25-019081DEFA14A

—

816.9 KB

DEF 14A

Oct 20, 2025

0001493152-25-018668DEF 14A

Dec 12, 2025

2.7 MB

10-Q

Oct 14, 2025

0001493152-25-01804310-Q

Aug 31, 2025

3.6 MB

PRE 14A

Oct 9, 2025

0001493152-25-017640PRE 14A

Oct 9, 2025

2.8 MB

8-K

Oct 8, 2025

0001493152-25-0173638-K

Oct 7, 2025

255.3 KB

10-K/A

Sep 26, 2025

0001493152-25-01578510-K/A

May 31, 2025

737.1 KB

10-K

Aug 29, 2025

0001641172-25-02604110-K

May 31, 2025

6.8 MB

8-K

Jun 6, 2025

0001641172-25-0139428-K

Jun 4, 2025

225.6 KB

Jun 6, 2025

0001641172-25-013941

Jun 4, 2025

4.2 KB

8-K

Apr 16, 2025

0001641172-25-004976

Apr 15, 2025

283.2 KB

10-Q

Apr 14, 2025

0001641172-25-004571

Feb 28, 2025

3.7 MB

SCHEDULE 13G

Feb 11, 2025

0000814133-25-000007

—

6.6 KB

10-Q

Jan 14, 2025

0001493152-25-002209

Nov 30, 2024

3.7 MB

S-8

Dec 20, 2024

0001493152-24-051087

—

119.6 KB

Dec 17, 2024

0001493152-24-050502

Dec 13, 2024

5.2 KB

Dec 17, 2024

0001493152-24-050501

Dec 13, 2024

5.3 KB

25 filings shown

Filed	Form	Description
2/11/25	SCHEDULE 13G	SCHEDULE 13G	→
9/29/23	EFFECT	EFFECT	→
9/30/20	EFFECT	EFFECT	→
2/27/20	D	D	→
7/20/17	EFFECT	EFFECT	→
8/26/16	CERTNAS	AUTO-GENERATED PAPER DOCUMENT	→
↓

BIOMERICA INC

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(585 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
10/23/25	DEFA14A	DEFA14A	→
10/20/25	DEF 14A	DEF 14A	→
10/9/25	PRE 14A	PRE 14A	→
9/30/24	DEF 14A	DEF 14A	→
9/20/24	PRE 14A	PRE 14A	→
9/27/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
1/28/26	4	4	→
12/31/25	4	4	→
12/31/25	4	4	→
12/31/25	4	4	→
12/31/25	4	4	→
12/31/25	4	4	→
↓